Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Palesch, Yuko
One or more keywords matched the following items that are connected to Palesch, Yuko
Item TypeName
Academic Article Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design.
Academic Article The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis.
Academic Article The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--I: Physiological responses and safety results.
Academic Article Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
Academic Article Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.
Concept Drug Therapy, Combination
Academic Article Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis.
Academic Article Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
Academic Article Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial.
Academic Article Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke.
Academic Article Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis.
Search Criteria
  • Drug Therapy Combination